Effect of Oxazepam during pregnancy and lactation

Oxazepam during pregnancy and lactation, Oxazepam category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Oxazepam  during pregnancy and lactation
Pregnancy	Category D      ( by FDA ) Category C      ( AU TGA )
	Oxazepam drug crosses the placenta during pregnancy, not recommended  during pregnancy, Teratogenicity - congenital malformations, risk for withdrawal symptoms, neonatal flaccidity, respiratory and feeding difficulties, and hypothermia in children born to mothers who have been taking benzodiazepines late in pregnancy
Breast feeding	Oxazepam excretes in milk in small amount. Effect on nursing infants is unknown, chronic use associated with lethargic and to lose weight.